— Know what they know.
Not Investment Advice

ANNX NASDAQ

Annexon, Inc.
1W: +1.3% 1M: -13.1% 3M: +11.0% YTD: +16.0% 1Y: +159.1% 3Y: -9.9% 5Y: -73.5%
$5.31
-0.13 (-2.39%)
 
Weekly Expected Move ±4.7%
$5 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 36 · $635.0M mcap · 128M float · 2.01% daily turnover · Short 61% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +100.0% ▲
Operating Income
-$216M -40.5% ▼
Net Income
-$209M -50.9% ▼
EPS (Diluted)
$-1.34 -32.7% ▼
EBITDA
-$216M -60.6% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$0$0$0$0$0
YoY Growth+0.0%+0.0%+0.0%+0.0%+0.0%
Cost of Revenue$0$0$0$3M$0
Gross Profit$0$0$0-$3M$0
Gross Margin
R&D Expenses$100M$113M$114M$119M$185M
SG&A Expenses$31M$31M$28M$35M$32M
Operating Expenses$131M$146M$144M$151M$216M
Operating Income-$131M-$146M-$144M-$154M-$216M
Operating Margin
Interest Expense$0$0$0$0$0
Income Before Tax-$130M-$142M-$134M-$138M-$209M
Tax Expense$0$0$0$0$0
Net Income-$130M-$142M-$134M-$138M-$209M
Net Margin
EPS (Diluted)$-3.34$-2.60$-1.77$-1.01$-1.34
EBITDA-$129M-$143M-$142M-$135M-$216M
Shares Outstanding38M55M76M137M155M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms